Neurosolutions was founded to provide technically demanding electrophysiology to the biopharmaceutical industry. Our highly qualified team of scientists deliver preclinical research solutions from the single cell right through to the whole animal tailored precisely to our client’s needs.
We are comfortable working on single fee-for-service contracts right up to multiple member research teams driving forward development programs under FTE agreements or as a working partnership. We incorporate the latest technologies in our pursuit of electrophysiological excellence, and deliver exceptional results ahead of schedule. We also provide animal behavioural and molecular biological services of the highest quality in parallel with our electrophysiological expertise.
“I have worked with NeuroSolutions on many projects over many years. The quality of the data is second to none, their scientific expertise and collaborative approach to our technicality demanding projects has been excellent. For example, the work on SEN1576 has led to high-impact joint publications with Senexis and this compound is now being developed by Talisman Therapeutics.”
Dr Mark Treherne
As former Chief Executive of Senexis Limited (Dr Treherne is currently Chief Executive of Life Sciences Organisation at UK Trade & Investment, which helps UK business trade overseas).